伴(1.5) hour credit (0.15 CEUs) and is co-sponsored

P Murphy, CS Roth, J Loggia, DW Montgomery - search.proquest.com
The efficacy of ezetimibe coadministered with simvastatin (in a range of doses from 10 mg-
40 mg) versus simvastatin alone in helping high-risk hypercholesterolemic patients reach …

Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult …

T Feldman, M Koren, W Insull Jr, J McKenney… - The American journal of …, 2004 - Elsevier
This study assessed whether the co-administration of ezetimibe and simvastatin would be
more effective than simvastatin monotherapy in allowing high-risk patients to achieve a low …

Ezetimibe coadministered with statin therapy significantly reduces LDL-C and improves goal attainment in patients with hypercholesterolemia

T Pearson, M Denke, P McBride, WP Battisti… - Southern Medical …, 2004 - go.gale.com
Ezetimibe (EZE), coadministered with a statin, offers a dual mechanism for lowering LDL-C.
In this randomized community-based clinical trial, we examined the effectiveness and safety …

A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the …

TA Pearson, MA Denke, PE McBride, WP Battisti… - Mayo Clinic …, 2005 - Elsevier
OBJECTIVE To determine the extent of reduction in low-density lipoprotein cholesterol (LDL-
C) level and improvement in National Cholesterol Education Program Adult Treatment Panel …

Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease

M Farnier, M Volpe, R Massaad, MJ Davies… - International journal of …, 2005 - Elsevier
OBJECTIVE: To determine whether co-administering ezetimibe with on-going simvastatin
treatment was more effective than placebo plus on-going simvastatin in achieving an LDL-C …

Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease

M Farnier, M Volpe, R Massaad, MJ Davies… - INTERNATIONAL …, 2005 - iris.uniroma1.it
OBJECTIVE: To determine whether co-administering ezetimibe with on-going simvastatin
treatment was more effective than placebo plus on-going simvastatin in achieving an LDL-C …

LDL-C goal attainment with the addition of ezetimibe to on-going simvastatin treatment in coronary heart disease patients with hypercholesterolemia

C Brohet, S Banai, AMW Alings… - … medical research and …, 2005 - Taylor & Francis
Objective: To evaluate the addition of ezetimibe or placebo to on-going simvastatin
treatment on attaining the LDL‐C treatment target of≤ 2.60 mmol/L (100 mg/dL) in coronary …

Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial …

PP Toth, CM Ballantyne, MH Davidson… - Journal of clinical …, 2012 - Elsevier
BACKGROUND: Recent trends suggest a decreased use of ezetimibe/simvastatin
combination and coadministered ezetimibe plus statin therapies. OBJECTIVE: This analysis …

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

CM Ballantyne, MA Blazing, TR King, WE Brady… - The American journal of …, 2004 - Elsevier
This study compared the efficacy and safety of co-administered ezetimibe+ simvastatin with
atorvastatin monotherapy in adults with hypercholesterolemia. Seven hundred eighty-eight …

Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different …

TA Pearson, MA Denke, PE McBride, WP Battisti… - Mayo Clinic …, 2006 - Elsevier
OBJECTIVE To examine whether the improvements in lipid profiles and low-density
lipoprotein cholesterol (LDL-C) goal attainment found in the Ezetimibe Add-On to Statin for …